Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The use of antiviral drugs during the neonatal period.

Whitley RJ.

Clin Perinatol. 2012 Mar;39(1):69-81. doi: 10.1016/j.clp.2011.12.004. Epub 2012 Jan 21. Review.

2.

[Congenital cytomegalovirus infection. The role of ganciclovir in newborns].

Aujard Y.

Arch Pediatr. 2014 Feb;21(2):121-4. doi: 10.1016/j.arcped.2013.11.008. Epub 2013 Dec 27. French. No abstract available.

PMID:
24377874
3.

[Antiviral chemotherapy].

Eggers HJ.

Monatsschr Kinderheilkd. 1986 Mar;134(3):122-9. German.

PMID:
3010086
4.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, Rathore M, Bradley JS, Diaz PS, Kumar M, Arvin AM, Gutierrez K, Shelton M, Weiner LB, Sleasman JW, de Sierra TM, Soong SJ, Kiell J, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..

Pediatrics. 2001 Aug;108(2):223-9.

PMID:
11483781
5.

Antiviral agents for treatment of herpes simplex virus infection in neonates.

Jones CA, Walker KS, Badawi N.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004206. doi: 10.1002/14651858.CD004206.pub2. Review.

PMID:
19588350
6.

Acyclovir and other chemotherapy for herpes group viral infections.

Balfour HH Jr.

Annu Rev Med. 1984;35:279-91. Review.

PMID:
6326661
7.

Advances in antiviral therapy: acyclovir.

Chadwick EG, Shulman ST.

Pediatr Dermatol. 1984 Jul;2(1):64-70. Review.

PMID:
6095238
8.

New antifungal and antiviral dosing.

Wade KC, Monk HM.

Clin Perinatol. 2015 Mar;42(1):177-94, x. doi: 10.1016/j.clp.2014.10.010. Epub 2014 Nov 25. Review.

PMID:
25678004
9.

Acyclovir- and ganciclovir-induced neurotoxicity.

Ernst ME, Franey RJ.

Ann Pharmacother. 1998 Jan;32(1):111-3. Review.

PMID:
9475829
10.
11.

Therapy for human herpesvirus infections. A perspective.

Whitley RJ.

Ala J Med Sci. 1985 Apr;22(2):193-207. Review. No abstract available.

PMID:
2988359
12.

In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.

Hostetler KY, Rybak RJ, Beadle JR, Gardner MF, Aldern KA, Wright KN, Kern ER.

Antivir Chem Chemother. 2001 Jan;12(1):61-70.

PMID:
11437323
13.

Treatment of herpesvirus infections in the immunocompromised host.

Meyers JD.

Scand J Infect Dis Suppl. 1985;47:128-36.

PMID:
2419973
14.

Management of neonatal herpes simplex virus infection.

Kesson AM.

Paediatr Drugs. 2001;3(2):81-90. Review.

PMID:
11269641
15.

Antiviral therapy. New drugs and their uses.

Bean B.

Postgrad Med. 1986 Jul;80(1):109-10, 113-4, 117-20. No abstract available.

PMID:
2425347
16.

[Antiviral therapy of immunocompromised patients].

Eggers HJ.

Immun Infekt. 1984 Aug;12(4):187-91. German.

PMID:
6090308
17.

Evaluation of ganciclovir for cytomegalovirus disease.

Fletcher CV, Balfour HH Jr.

DICP. 1989 Jan;23(1):5-12. Review.

PMID:
2541566
18.

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection.

Crowley B.

J Antimicrob Chemother. 2002 Sep;50(3):435-6; author reply 436. No abstract available.

PMID:
12205075
19.
20.

Acyclovir. Is the honeymoon coming to an end?

Welsby PD.

J Infect. 1994 Mar;28(2):121-9. Review. No abstract available.

PMID:
8034991

Supplemental Content

Support Center